ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

October 4, 2002

In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science

January 13, 1995

RFPs Available, NIH Funding Strategies

February 18, 1994

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies

June 29, 2001